Public-registry site landscape for NCT07728188, a Relapsed or Refractory Multiple Myeloma study sponsored by AbbVie. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07728188 (registry record) |
| Sponsor | AbbVie |
| Condition(s) | Relapsed or Refractory Multiple Myeloma |
| Phase | PHASE3 |
| Listed sites | 66 |
| Site countries | United States, Australia, Canada, France, Germany, Hungary, Italy, Netherlands, Norway, Portugal, Spain, Taiwan |
Eichor generates a preliminary site-risk snapshot for NCT07728188 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →